ArticleExperimental and therapeutic medicine2018

Efficacy and safety of baricitinib for active rheumatoid arthritis in patients with an inadequate response to conventional synthetic or biological disease-modifying anti-rheumatic drugs: A meta-analysis of randomized controlled trials.

Zhi-Peng Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.